Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)
UPSAC
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this study is to analyze and identify pre-, intra-, and post- operative parameters that predict Steal-Syndrome with distal malperfusion after Arterio-Venous Fistulas (AVF) as primary endpoint. Secondary endpoints are pre-, intra-, and post- operative parameters that predict patency and fistula maturation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 3, 2011
CompletedFirst Posted
Study publicly available on registry
November 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedSeptember 25, 2014
September 1, 2014
3 years
November 3, 2011
September 23, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Steal-Syndrome
Steal Syndrome as defined according to the guidelines of the Society of Vascular Surgery (SVS): Asymptomatic (pulse deficits, doppler signal attenuation, and distal flow reversal) Mild Ischemia: slight coldness and numbness that occurs only during dialysis, may be self-limited, and may resosolve without treatment, and Severe Ischemia: Can be permanent and may be associated with constant pain, severe numbness, digital cyanosis or gangrene, finger contracture, or amputation of a digit hand or forearm. Standard assessment for steal syndrom at 5-10 days, 4-6 weeks, 6 months, and 1 year.
1 year
Secondary Outcomes (2)
Time to fistula maturation
1 year
Fistula patency
1 year
Study Arms (1)
Fistula patients
Consecutive patients with autogenous, brachio-cephalic, brachio-basilic or brachio-brachial arterio-venous fistula creation for hemodialysis
Eligibility Criteria
Patients selected for this protocol must have the necessity to undergo surgery to receive an Arterio-Venos Fistula (AVF) for hemodialysis in either arm.
You may qualify if:
- Patients 18 years of age
- Autogenous, brachio-cephalic, brachio-basilic or brachio-brachial Arterio- Venous Fistula creation for hemodialysis
- General preoperative requirements for this surgery passed
- Patients willing to adhere to the follow-up
- Patients able to understand and provide informed consent
You may not qualify if:
- Less than 18 years of age
- Patient is unable or unwilling to provide consent
- Prosthetic graft creation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baptist Hospital of Miami, Baptist Cardiac and Vascular Institute
Miami, Florida, 33176, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Athanassios Tsoukas, MD
Baptist Hospital Miami, BCVI
- PRINCIPAL INVESTIGATOR
Heiko Uthoff, MD
Baptist Hospital Miami, BCVI
- PRINCIPAL INVESTIGATOR
Philipp Geisbuesch, MD
Baptist Hospital Miami, BCVI
- STUDY DIRECTOR
Raul Herrera, MD
Baptist Hospital of Miami, Baptist Cardiac and Vascular Institute
- PRINCIPAL INVESTIGATOR
Barry Katzen, MD
Medical Director Baptist Cardiac and Vascular Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Clinical Research, Baptist Hospital of Miami, BCVI
Study Record Dates
First Submitted
November 3, 2011
First Posted
November 9, 2011
Study Start
September 1, 2011
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
September 25, 2014
Record last verified: 2014-09